BIOINCYTE LTD
Executive Summary
BIOINCYTE LTD is a micro-sized publisher with strong leadership alignment but facing significant financial strain as reflected in its growing net liabilities and negative equity. Its lean structure and niche focus provide agility, yet limited resources constrain scalability and market penetration. To unlock growth, the company should prioritize financial stabilization and leverage digital publishing innovations and partnerships to expand its content reach and revenue base, while mitigating operational risks inherent in its current scale.
View Full Analysis Report →- Legal registered address
- 10 Broad Walk Stratford-Upon-Avon England CV37 6HS Copied!
Latest financial results as of 30 September 2025- Current assets
- £45.62k
- Fixed assets
- £298
- Current creditors
- £71.93k
- Shareholders funds
- £-100.90k
View full financial accounts- Current assets
- £45.62k
- Fixed assets
- £298
- Current creditors
- £71.93k
- Shareholders funds
- £-100.90k
- Company number
- 13037659 Copied!
Accounts
Latest annual accounts were to 31 December 2024
Next annual accounts are due by 30 September 2026
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 3 April 2025
Next statement due by 17 April 2026
Nature of business (SIC)
58190 - Other publishing activities
Latest company documents
Date | Description |
---|---|
29/09/2529 September 2025 New | Micro company accounts made up to 2024-12-31 |
28/04/2528 April 2025 | Appointment of Mr Nicholas David Best as a director on 2025-04-06 |
15/04/2515 April 2025 | Confirmation statement made on 2025-04-03 with updates |
11/04/2411 April 2024 | Confirmation statement made on 2024-04-03 with updates |
31/12/2331 December 2023 | Annual accounts for year ending 31 Dec 2023 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company